Baker McKenzie is acting as international counsel to McKesson Corporation (NYSE: MCK) on its acquisition of Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services for approximately USD 2.25 billion.
Led by M&A Partner Darcy Down, the core team included:
Corporate / M&A: Collin Stich, Angus Duncan
IP / Data: Adam Aft, Keo McKenzie, Robby Turner
Regulatory: Lois Sheng Liu, Jing Xu
Employment: Kimberly Franko, Benjamin Durst
Compensation: M’Alyssa Mecenas, Sesen Hailemichael, Jill Sparkman
Real Estate: Sarah Swain
Lawyers from around the Firm formed part of Baker McKenzie’s wider transactional team.
Learn more about the transaction: McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
Baker McKenzie is a global transactional leader, with more than 2,500 deal practitioners across 40+ countries advising on complex and cross‑border transactions. With one of the largest Healthcare & Life Sciences teams of any international law firm, the Firm combines deep sector knowledge and a global platform to execute high‑stakes matters at the intersection of innovation, regulation and M&A.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.